Related Experiment Video

Updated: May 11, 2026

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
14:04

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria

Published on: May 8, 2013

Discovery of antivirulence agents against methicillin-resistant Staphylococcus aureus

Varandt Khodaverdian1, Michelle Pesho, Barbara Truitt

  • 1Department of Biochemistry, School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.

Antimicrobial Agents and Chemotherapy
|May 22, 2013
PubMed

Insights

New antivirulence agents targeting methicillin-resistant Staphylococcus aureus (MRSA) were identified. These compounds inhibit MRSA toxins without affecting bacterial growth, offering a novel therapeutic approach.

Area of Science:

  • Microbiology
  • Pharmacology
  • Infectious Diseases

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) USA300 is a prevalent U.S. pathogen.
  • Virulence factors are key targets for novel antimicrobial strategies.
  • Antivirulence agents offer an alternative to traditional antibiotics by disarming bacteria.

Purpose of the Study:

  • To discover novel antivirulence agents against MRSA USA300.
  • To identify compounds that inhibit key MRSA toxins and virulence factors.
  • To explore repurposing existing drugs as antivirulence agents.

Main Methods:

  • Virtual screening of small molecules against the MRSA response regulator AgrA.
  • Similarity searches in commercial compound databases.
  • In vitro testing of identified compounds for inhibition of bacterial growth and toxin production.

Main Results:

  • Discovery of small-molecule biaryl compounds that inhibit alpha-hemolysin and phenol-soluble modulin α production.
  • Inhibition of toxins was dose-dependent and occurred without impacting bacterial growth.
  • Diflunisal, an FDA-approved NSAID, was identified as a potential antivirulence agent.

Conclusions:

  • Novel antivirulence agents targeting MRSA USA300 have been identified.
  • These agents represent a promising strategy for combating MRSA infections.
  • Diflunisal shows potential for repurposing as an antivirulence therapeutic.

More Related Videos

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)

Published on: February 9, 2011

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...